Researcher Services

Research Departments

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Hutchinson AK, Kraker RT, Pineles SL, VanderVeen DK, Wilson LB, Galvin JA, Lambert SR. Ophthalmic Technology Assessment: The Use of Beta-Blockers for the Treatment of Periocular Hemangiomas in Infants. Ophthalmology. 2018 Jul 31. View abstract
  2. Lambert SR, Kraker RT, Pineles SL, Hutchinson AK, Wilson LB, Galvin JA, VanderVeen DK. Contact Lens Correction of Aphakia in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018 Apr 06. View abstract
  3. Vavvas DG, Dryja TP, Wilson ME, Olsen TW, Shah A, Jurkunas U, Pineda R, Poulaki V, Palioura S, Veldman P, Moreno-Montañés J, Pinazo-Duran MD, Pastor JC, Tsilimbaris M, Rhee D, Colby K, Hunter DG, Thanos S, Sakamoto T, Pasquale LR, Miller JW, VanderVeen D, Lambert SR. Lens regeneration in children. Nature. 2018 04 04; 556(7699):E2-E3. View abstract
  4. VanderVeen DK. Weighing in on New Screening Models for Retinopathy of Prematurity. JAMA Ophthalmol. 2018 Apr 01; 136(4):417-418. View abstract
  5. Koo EB, VanderVeen DK, Lambert SR. Global Practice Patterns in the Management of Infantile Cataracts. Eye Contact Lens. 2018 Jan 15. View abstract
  6. Holm M, Morken TS, Fichorova RN, VanderVeen DK, Allred EN, Dammann O, Leviton A. Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation. Invest Ophthalmol Vis Sci. 2017 12 01; 58(14):6419-6428. View abstract
  7. Indaram M, VanderVeen DK. Postoperative Refractive Errors Following Pediatric Cataract Extraction with Intraocular Lens Implantation. Semin Ophthalmol. 2018; 33(1):51-58. View abstract
  8. Nihalani BR, VanderVeen DK. Response to: 'Unmet needs of cataract blind children in special schools in Southeast Nigeria'. Eye (Lond). 2018 02; 32(2):471. View abstract
  9. Pineles SL, Kraker RT, VanderVeen DK, Hutchinson AK, Galvin JA, Wilson LB, Lambert SR. Atropine for the Prevention of Myopia Progression in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 12; 124(12):1857-1866. View abstract
  10. Wallace DK, Kraker RT, Freedman SF, Crouch ER, Hutchinson AK, Bhatt AR, Rogers DL, Yang MB, Haider KM, VanderVeen DK, Siatkowski RM, Dean TW, Beck RW, Repka MX, Smith LE, Good WV, Hartnett ME, Kong L, Holmes JM. Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study. JAMA Ophthalmol. 2017 Jun 01; 135(6):654-656. View abstract
  11. VanderVeen DK, Melia M, Yang MB, Hutchinson AK, Wilson LB, Lambert SR. Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017 05; 124(5):619-633. View abstract
  12. Wilson ME, Lambert SR, Plager DA, VanderVeen D, Roarty J, O'Halloran H. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2017 03; 31(3):506-507. View abstract
  13. Nihalani BR, VanderVeen DK. Benchmarks for outcome indicators in pediatric cataract surgery. Eye (Lond). 2017 Mar; 31(3):417-421. View abstract
  14. Bothun ED, Lynn MJ, Christiansen SP, Kruger SJ, Vanderveen DK, Neely DE, Lambert SR. Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years. J AAPOS. 2016 Dec; 20(6):501-505. View abstract
  15. Koo EB, Gilbert AL, VanderVeen DK. Treatment of Amblyopia and Amblyopia Risk Factors Based on Current Evidence. Semin Ophthalmol. 2017; 32(1):1-7. View abstract
  16. Ying GS, VanderVeen D, Daniel E, Quinn GE, Baumritter A. Risk Score for Predicting Treatment-Requiring Retinopathy of Prematurity (ROP) in the Telemedicine Approaches to Evaluating Acute-Phase ROP Study. Ophthalmology. 2016 10; 123(10):2176-82. View abstract
  17. Wilson ME, O'Halloran H, VanderVeen D, Roarty J, Plager DA, Markwardt K, Gedif K, Lambert SR. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study. Eye (Lond). 2016 Sep; 30(9):1187-94. View abstract
  18. Traboulsi EI, Vanderveen D, Morrison D, Drews-Botsch CD, Lambert SR. Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience. Eye (Lond). 2016 Sep; 30(9):1170-4. View abstract
  19. Bothun ED, Lynn MJ, Christiansen SP, Neely DE, Vanderveen DK, Kruger SJ, Lambert SR. Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS). J AAPOS. 2016 Feb; 20(1):49-53. View abstract
  20. Hutchinson AK, Melia M, Yang MB, VanderVeen DK, Wilson LB, Lambert SR. Clinical Models and Algorithms for the Prediction of Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology. Ophthalmology. 2016 Apr; 123(4):804-16. View abstract
  21. Kemp PS, VanderVeen DK. Computer-Assisted Digital Image Analysis of Plus Disease in Retinopathy of Prematurity. Semin Ophthalmol. 2016; 31(1-2):159-62. View abstract
  22. VanderVeen DK, Allred EN, Wallace DK, Leviton A. Strabismus at Age 2 Years in Children Born Before 28 Weeks' Gestation: Antecedents and Correlates. J Child Neurol. 2016 Mar; 31(4):451-60. View abstract
  23. Lundgren P, Stoltz Sjöström E, Domellöf M, Smith L, Wu C, VanderVeen D, Hellström A, Löfqvist C. The Specificity of the WINROP Algorithm Can Be Significantly Increased by Reassessment of the WINROP Alarm. Neonatology. 2015; 108(2):152-6. View abstract
  24. Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015 Feb; 62(1):201-23. View abstract
  25. Wan MJ, VanderVeen DK. Eye disorders in newborn infants (excluding retinopathy of prematurity). Arch Dis Child Fetal Neonatal Ed. 2015 May; 100(3):F264-9. View abstract
  26. Lee JW, VanderVeen D, Allred EN, Leviton A, Dammann O. Prethreshold retinopathy in premature infants with intrauterine growth restriction. Acta Paediatr. 2015 Jan; 104(1):27-31. View abstract
  27. Yonekawa Y, Shah AS, France RM, Ciarlini P, VanderVeen DK. Leukocoria in a 2-year-old boy. J Paediatr Child Health. 2014 Sep; 50(9):744, 747. View abstract
  28. Whitman MC, Vanderveen DK. Complications of pediatric cataract surgery. Semin Ophthalmol. 2014 Sep-Nov; 29(5-6):414-20. View abstract
  29. Monroy JE, Orbach DB, VanderVeen D. Complications of intra-arterial chemotherapy for retinoblastoma. Semin Ophthalmol. 2014 Sep-Nov; 29(5-6):429-33. View abstract
  30. Jakobiec FA, Trief D, Rashid A, Rose MF, Minckler D, Vanderveen D, Mukai S. New insights into the development of infantile intraocular medulloepithelioma. Am J Ophthalmol. 2014 Dec; 158(6):1275-1296.e1. View abstract
  31. VanderVeen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR. Reply: To PMID 24011524. Am J Ophthalmol. 2014 Jun; 157(6):1332-3. View abstract
  32. Allred EN, Capone A, Fraioli A, Dammann O, Droste P, Duker J, Gise R, Kuban K, Leviton A, O'Shea TM, Paneth N, Petersen R, Trese M, Stoessel K, Vanderveen D, Wallace DK, Weaver G. Retinopathy of prematurity and brain damage in the very preterm newborn. J AAPOS. 2014 Jun; 18(3):241-7. View abstract
  33. Orbach DB, Vanderveen DK, Shah AS, Rodriguez-Galindo C. Blue toe syndrome: a complication of intra-arterial technique, not intra-arterial chemotherapy for retinoblastoma. JAMA Ophthalmol. 2014 May; 132(5):654. View abstract
  34. Vanderveen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR. Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol. 2013 Dec; 156(6):1252-1260.e2. View abstract
  35. Yonekawa Y, Orbach DB, Trief D, Shah AS, Vanderveen DK. Intra-arterial chemotherapy for group C retinoblastoma with adjacent high-flow infantile hemangioma. Ophthalmic Surg Lasers Imaging Retina. 2013 Sep-Oct; 44(5):490-2. View abstract
  36. Sadiq MA, Vanderveen D. Genetics of ectopia lentis. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):313-20. View abstract
  37. Ramasubramanian A, Mantagos I, Vanderveen DK. Corneal endothelial cell characteristics after pediatric cataract surgery. J Pediatr Ophthalmol Strabismus. 2013 Jul-Aug; 50(4):251-4. View abstract
  38. VanderVeen DK, Martin CR, Mehendale R, Allred EN, Dammann O, Leviton A. Early nutrition and weight gain in preterm newborns and the risk of retinopathy of prematurity. PLoS One. 2013; 8(5):e64325. View abstract
  39. Yonekawa Y, Vanderveen DK, Shah AS. Congenital glaucoma. J Pediatr. 2013 Jul; 163(1):301. View abstract
  40. Nihalani BR, VanderVeen DK. Uncorrected visual acuity in children with monofocal pseudophakia. J Cataract Refract Surg. 2013 Mar; 39(3):419-24. View abstract
  41. Bothun ED, Cleveland J, Lynn MJ, Christiansen SP, Vanderveen DK, Neely DE, Kruger SJ, Lambert SR. One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology. 2013 Jun; 120(6):1227-31. View abstract
  42. Young MP, Heidary G, VanderVeen DK. Relationship between the timing of cataract surgery and development of nystagmus in patients with bilateral infantile cataracts. J AAPOS. 2012 Dec; 16(6):554-7. View abstract
  43. Wang CJ, Little AA, Kamholz K, Holliman JB, Wise MD, Davis J, Ringer S, Cole C, Vanderveen DK, Christiansen SP, Bauchner H. Improving preterm ophthalmologic care in the era of accountable care organizations. Arch Ophthalmol. 2012 Nov; 130(11):1433-40. View abstract
  44. Nihalani BR, Vanderveen DK. Accuracy of intraocular lens power calculation formulae in children less than two years. Am J Ophthalmol. 2012 Oct; 154(4):759-60; author reply 760. View abstract
  45. Wu C, Löfqvist C, Smith LE, VanderVeen DK, Hellström A. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012 Aug; 130(8):992-9. View abstract
  46. Salgado C, Neff T, Frazier L, Vargas SO, Vanderveen D. An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis. J Pediatr Hematol Oncol. 2012 Mar; 34(2):e69-71. View abstract
  47. VanderVeen DK, Nizam A, Lynn MJ, Bothun ED, McClatchey SK, Weakley DR, DuBois LG, Lambert SR. Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol. 2012 Mar; 130(3):293-9. View abstract
  48. VanderVeen DK, Andrews C, Nihalani BR, Engle EC. Crystalline cataract caused by a heterozygous missense mutation in ?D-crystallin (CRYGD). Mol Vis. 2011; 17:3333-8. View abstract
  49. VanderVeen DK, Bremer DL, Fellows RR, Hardy RJ, Neely DE, Palmer EA, Rogers DL, Tung B, Good WV. Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS. 2011 Dec; 15(6):536-40. View abstract
  50. Nihalani BR, Vanderveen DK. Secondary intraocular lens implantation after pediatric aphakia. J AAPOS. 2011 Oct; 15(5):435-40. View abstract
  51. Chen ML, Allred EN, Hecht JL, Onderdonk A, VanderVeen D, Wallace DK, Leviton A, Dammann O. Placenta microbiology and histology and the risk for severe retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2011 Sep 01; 52(10):7052-8. View abstract
  52. Salcone EM, Johnston S, VanderVeen D. Review of the use of digital imaging in retinopathy of prematurity screening. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):214-7. View abstract
  53. Nihalani BR, VanderVeen DK. Technological advances in pediatric cataract surgery. Semin Ophthalmol. 2010 Sep-Nov; 25(5-6):271-4. View abstract
  54. Hauspurg AK, Allred EN, Vanderveen DK, Chen M, Bednarek FJ, Cole C, Ehrenkranz RA, Leviton A, Dammann O. Blood gases and retinopathy of prematurity: the ELGAN Study. Neonatology. 2011; 99(2):104-11. View abstract
  55. Nihalani BR, VanderVeen DK. Comparison of intraocular lens power calculation formulae in pediatric eyes. Ophthalmology. 2010 Aug; 117(8):1493-9. View abstract
  56. Motley WW, Vanderveen DK, West CE. Surgical management of infantile cataracts in dystrophic epidermolysis bullosa. J AAPOS. 2010 Jun; 14(3):283-4. View abstract
  57. Wu C, Vanderveen DK, Hellström A, Löfqvist C, Smith LE. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010 Apr; 128(4):443-7. View abstract
  58. Mehta M, Mansfield T, VanderVeen DK. Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. J Perinatol. 2010 Nov; 30(11):731-5. View abstract
  59. Salgado CM, Celik Y, VanderVeen DK. Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity. Am J Ophthalmol. 2010 Jul; 150(1):6-9.e2. View abstract
  60. Rudloe TF, Harper MB, Prabhu SP, Rahbar R, Vanderveen D, Kimia AA. Acute periorbital infections: who needs emergent imaging? Pediatrics. 2010 Apr; 125(4):e719-26. View abstract
  61. Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol. 2009 Mar-Apr; 24(2):77-81. View abstract
  62. Mantagos IS, Vanderveen DK, Smith LE. Emerging treatments for retinopathy of prematurity. Semin Ophthalmol. 2009 Mar-Apr; 24(2):82-6. View abstract
  63. Wong RK, VanderVeen DK. Presentation and management of congenital dacryocystocele. Pediatrics. 2008 Nov; 122(5):e1108-12. View abstract
  64. Vanderveen DK, Nihalani BR, Barron P, Anderson RL. Optic nerve sheath fenestration for an isolated optic nerve glioma. J AAPOS. 2009 Feb; 13(1):88-90. View abstract
  65. Vanderveen DK. Cataract update 2008: all you need to know about your pediatric cataract patients. Binocul Vis Strabismus Q. 2008; 23(3):145-58. View abstract
  66. Krishnamurthy R, Vanderveen DK. Infantile cataracts. Int Ophthalmol Clin. 2008; 48(2):175-92. View abstract
  67. Jones DT, Fajardo NF, Petersen RA, VanderVeen DK. Pediatric endoscopic dacryocystorhinostomy failures: who and why? Laryngoscope. 2007 Feb; 117(2):323-7. View abstract
  68. Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS. 2006 Oct; 10(5):445-8. View abstract
  69. VanderVeen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ, Neely DE, Palmer EA, Steidl SM, Tung B, Good WV. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol. 2006 Jun; 124(6):766-73. View abstract
  70. Wu C, Petersen RA, VanderVeen DK. RetCam imaging for retinopathy of prematurity screening. J AAPOS. 2006 Apr; 10(2):107-11. View abstract
  71. Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005 Dec; 46(12):4734-8. View abstract
  72. Vanderveen DK, Jones DT, Tan H, Petersen RA. Endoscopic dacryocystorhinostomy in children. J AAPOS. 2001 Jun; 5(3):143-7. View abstract
  73. Fulton AB, Hansen RM, Petersen RA, Vanderveen DK. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol. 2001 Apr; 119(4):499-505. View abstract
  74. Stephan DA, Gillanders E, Vanderveen D, Freas-Lutz D, Wistow G, Baxevanis AD, Robbins CM, VanAuken A, Quesenberry MI, Bailey-Wilson J, Juo SH, Trent JM, Smith L, Brownstein MJ. Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene. Proc Natl Acad Sci U S A. 1999 Feb 02; 96(3):1008-12. View abstract
  75. VanderVeen DK, Pasquale LR, Fulton AB. Central retinal vein occlusion in a young child with cyanotic heart disease. Arch Ophthalmol. 1997 Aug; 115(8):1077. View abstract